| Code | 37266 | ||||||||||
| MA number | 34/0500/06-S | ||||||||||
| Product Form: | tbl 50x0,5 mg (fľ.skl.hnedá) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | TEVA Pharmaceuticals Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 34 - ANTIHORMONA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | brown glass bottle | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 06.12.2006 |
| Pediatric indication: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Cabest 0,5 mg_11_2022.pdf
|
| PIL: |
PIL_Cabest 0,5 mg_11_2022.pdf
|
| Safety feature | Yes |
| Data update: | 20.11.2018 |
